SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2022 | $98,605 | -39.2% | 2,979 | -21.8% | 0.03% | -37.0% |
| Q4 2021 | $162,077 | -4.0% | 3,810 | 0.0% | 0.05% | -12.9% |
| Q3 2021 | $168,821 | -22.0% | 3,810 | 0.0% | 0.06% | -21.5% |
| Q2 2021 | $216,446 | -24.1% | 3,810 | 0.0% | 0.08% | -29.5% |
| Q1 2021 | $285,179 | -13.5% | 3,810 | 0.0% | 0.11% | -20.0% |
| Q4 2020 | $329,603 | +41.5% | 3,810 | 0.0% | 0.14% | +23.9% |
| Q3 2020 | $232,867 | +47.0% | 3,810 | 0.0% | 0.11% | +36.1% |
| Q2 2020 | $158,420 | +1367.0% | 3,810 | +913.3% | 0.08% | +1085.7% |
| Q1 2020 | $10,799 | +9.5% | 376 | +496.8% | 0.01% | 0.0% |
| Q2 2018 | $9,861 | – | 63 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |